<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1182">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01639586</url>
  </required_header>
  <id_info>
    <org_study_id>2011-A00167-34</org_study_id>
    <nct_id>NCT01639586</nct_id>
  </id_info>
  <brief_title>Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care</brief_title>
  <acronym>COMPARSE</acronym>
  <official_title>Comparaison du Service Rendu à la Personne Atteinte d'Une Maladie d'Alzheimer et de l'Aidant Par Trois Types de Prises en Charge (Plateforme, Accueil de Jour et Groupe contrôle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Department of Clinical Research and Innovation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the interests of the Alzheimer Plan 2008-2010 is to provide increase support to&#xD;
      helping families. It's also of major to involve the patient in the most active treatment&#xD;
      possible, encouraging social inter relationship as well as cognitive and behavioural&#xD;
      stimulation activities.&#xD;
&#xD;
      In the frame of non drug related approaches to Alzheimer disease (AD), several research&#xD;
      projects and actions have already been conducted, but no specific study concerning the&#xD;
      efficiency of different types of respite care structures have been conducted so far in&#xD;
      France. The present project concerns the thematic of the frame &quot;Development and&#xD;
      diversification of respite care structures&quot;.&#xD;
&#xD;
      A platform is defined in the Alzheimer Plan as a &quot;diversified range of despite structures&#xD;
      according to patients' needs and informal caregivers' expectations&quot; providing several&#xD;
      objectives:&#xD;
&#xD;
      Two objectives targeting the informal caregivers:&#xD;
&#xD;
        -  offer spare time or tutored&#xD;
&#xD;
        -  inform, support and accompany&#xD;
&#xD;
      Two objectives targeting the patients:&#xD;
&#xD;
        -  encourage maintain of the patient social life and relationships and work together&#xD;
           towards his/her psychological and emotional well-being&#xD;
&#xD;
        -  contribute to improve functional cognitive and sensory capacities&#xD;
&#xD;
      The study COMPARSE suggests to compare for the patient - informal caregiver couple, the&#xD;
      impact of three different groups of patient care on health profit; resit platform (P), the&#xD;
      day care group (D), the control group without access to a respite structure (C).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of the perceived and diagnosed health evolution of the patient</measure>
    <time_frame>at baseline, one month and nine month</time_frame>
    <description>Realize neuropsychological evaluation and satisfaction degree evaluation of the patient and the informal caregiver to compare different types of respite care structures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacity of the different structures</measure>
    <time_frame>at baseline, one month and nine month</time_frame>
    <description>Assess autonomy level of patient Realize sociological qualitative analysis and economic evaluation by comparing differents structures</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Impact of the day care on health profit of patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No access to a respite structure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Respite platform</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>respite platform</intervention_name>
    <description>Impact of the respite platform patient care on health profit</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Day care</intervention_name>
    <description>Impact of the day care on health profit of patient</description>
    <arm_group_label>D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>No access to a respite structure</intervention_name>
    <description>Control group without access to a respite structure</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  patient affect by Alzheimer disease or related pathology&#xD;
&#xD;
          -  patient with an informal caregiver&#xD;
&#xD;
          -  patient not using any respite structure&#xD;
&#xD;
          -  signed informed consent (patient and informal caregiver)&#xD;
&#xD;
          -  affiliate to social security&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  patient without informal caregiver&#xD;
&#xD;
          -  patient include in another clinical protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Pradier, PHD MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Département de Santé Publique - CHU de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Franck Le Duff, MD</last_name>
    <phone>04 92 03 47 70</phone>
    <email>leduff.f@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lauriane Garcia, Clinical Research Associate</last_name>
    <phone>04 92 03 47 70</phone>
    <email>garcia.l@chu-nice.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Le Duff</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Franck Le Duff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <study_first_submitted>March 23, 2012</study_first_submitted>
  <study_first_submitted_qc>July 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2012</study_first_posted>
  <last_update_submitted>July 10, 2012</last_update_submitted>
  <last_update_submitted_qc>July 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Nice</investigator_affiliation>
    <investigator_full_name>Department of Clinical Research and Innovation</investigator_full_name>
    <investigator_title>Department of Clinical Research and Innovation (drc)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

